Using Doxepin for Urticaria

Status Recruiting

Clinical Trial Summary

Isolated urticaria in the emergency department is widely treated by physicians with histamine blocking agents such as diphenhydramine, cetirizine, and cimetidine. Doxepin is a tricyclic antidepressant that has been shown to have much higher concentrations of histamine blocking activity and therefore may be useful in treating urticaria. The purpose of this study is to compare the effectiveness of using doxepin verses a traditional medication, diphenhydramine (Benadryl), in the treatment of isolated urticaria in the emergency department.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Urticaria

Clinical Trial Details

NCT number	NCT05115136
Study type	Interventional
Source	State University of New York - Upstate Medical University
Contact	David Andonian, MD
Phone	315-464-4363
Email	andoniad@upstate.edu
Status	Recruiting
Phase	Phase 3
Start date	May 23, 2022
Completion date	July 1, 2023

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT03693625` - A Study to Evaluate the Long-term Safety and Efficacy of Fenebrutinib in Participants Previously Enrolled in a Fenebrutinib Chronic Spontaneous Urticaria (CSU) Study	Phase 2
Recruiting	`NCT03545464` - COrticosteroids in acUte uRticAria in emerGency dEpartment	Phase 3
Completed	`NCT00541255` - A Long-Term Examination of Asthma From Childhood Through Adolescence
Not yet recruiting	`NCT00163839` - The Efficacy of a Pseudoallergen-Free Diet in the Treatment of Chronic Idiopathic Urticaria and/or Angioedema	N/A
Terminated	`NCT00069329` - Anakinra to Treat Patients With Neonatal Onset Multisystem Inflammatory Disease	N/A
Completed	`NCT00876369` - Vitamin D Levels in Subjects With Chronic Urticaria and Angioedema
Terminated	`NCT00199238` - Efficacy of Rupatadine 5, 10 and 20 mg in Chronic Idiopathic Urticaria	Phase 2
Completed	`NCT02576041` - Effects of Bilastine on F1 Simulator Driving Performance in Patients Affected by Allergic Rhinitis and/or Urticaria	Phase 4
Completed	`NCT02238249` - Study to Investigate the Safety and Efficacy of Alesion® in Japanese Paediatric Patients With Urticaria	N/A
Completed	`NCT00724698` - Evaluation of Desloratadine When Used in Patients With Either Allergic Rhinitis or Chronic Idiopathic Urticaria
Completed	`NCT00001150` - Induction of Suction Blisters in Patients With Urticaria, Blistering Diseases, Inflammatory Dermatoses and Neoplastic Disorders, and in Normal Volunteers	N/A
Completed	`NCT03296358` - Adding a Short Burst of Corticosteroid to the Conventional Treatment of H1 Antihistamines in Emergency Department.	N/A
Completed	`NCT00130234` - Effect of Anti-IgE in Chronic Urticaria	Phase 2
Completed	`NCT00795158` - How Desloratadine (Clarinex, Aerius) Affects Quality of Life in Patients With Chronic Idiopathic Urticaria (Have Had Hives for 6 Weeks or Longer)(Study P02988)	Phase 3
Completed	`NCT00368823` - A Trial of Point of Care Information in Ambulatory Pediatrics	Phase 3
Completed	`NCT02424799` - Study to Investigate Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of GSK2646264	Phase 1
Completed	`NCT01371877` - The Role of Vitamin D in Chronic Urticaria and Angioedema Treatment	N/A
Completed	`NCT00751218` - A Comparative Double-Blind, Double- Dummy Study of Desloratadine (DL) 5 MG Once Daily, Cetirizine 10 MG Once Daily, and Placebo Once Daily in Patients With Chronic Idiopathic Urticaria (Study P03735)	Phase 4
Completed	`NCT03137069` - A Study of GDC-0853 in Participants With Refractory Chronic Spontaneous Urticaria (CSU).	Phase 2
Terminated	`NCT02382562` - Brief Behavioral Activation Intervention for Depressed Asthma and Urticaria Patients	N/A